AFFY — Affymax Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.09m
- -$3.31m
- $1.37m
Annual income statement for Affymax, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2009 December 31st | 2010 December 31st | 2011 December 31st | 2012 December 31st | 2013 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 115 | 113 | 47.7 | 94.4 | 1.37 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 194 | 127 | 109 | 186 | 16.4 |
| Operating Profit | -78.9 | -14.4 | -61.4 | -92 | -15 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -77.9 | -14.1 | -61.4 | -93.4 | -16.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -76.5 | -14.1 | -61.4 | -93.4 | -14.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -76.5 | -14.1 | -61.4 | -93.4 | -14.4 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -76.5 | -14.1 | -61.4 | -93.4 | -14.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -4.06 | -0.575 | -1.84 | -0.688 | -0.784 |
| Dividends per Share |